Regenerative medicine with organ-on-chip technology involves creating microscale replicas of human organs that can be used for various biomedical applications, including disease modeling, drug development, and personalized medicine.
Current methods for drug testing often use animal models or cell cultures, which are not always representative of human physiology. This technology provides a more accurate model for testing the efficacy and safety of drugs before clinical trials, as well as personalized treatment options based on individual patient responses.
These devices are fabricated using microfabrication techniques to replicate the structure and function of real organs. They consist of multiple layers with channels and chambers that mimic the organ's microenvironment, allowing cells to grow and interact in a way that closely resembles their natural environment. Fluids can be perfused through these channels to simulate blood flow or other physiological conditions.
The manufacturing process involves microfabrication techniques such as photolithography, soft lithography, and microfluidics to create the organ-on-chip devices. Cells are then seeded into these structures using biocompatible materials like polydimethylsiloxane (PDMS) or polymer-based substrates.
The build process includes design, fabrication of the microchannels and chambers, cell seeding, and integration with external systems for fluid perfusion and monitoring. The devices are typically fabricated in cleanroom environments to ensure sterility and quality control.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.